GoldenGolden
Perlegen Sciences

Perlegen Sciences

Perlegen Sciences is a Biotechnology ompany

Perlegen was founded in late 2000 by David R. Cox. It identifies the patterns of genetic differences between people and uses the data to make patient care better and also discover the genetic foundations of diseases.

Timeline

January 2006
Perlegen Sciences raises a $50,000,000 series D round from CMEA Capital, Cape Securities, Glynn Capital Management, Maverick Ventures, Mizuho Securities, Private Life Biomed, SB Life Science, Sano Ventures, Unilever Ventures and Zesiger Capital.
February 2005
Perlegen Sciences raises a $74,000,000 series D round from CMEA Capital, CSK Venture Capital, Glynn Capital Management, Maverick Ventures, Mizuho Securities, Private Life Biomed, SB Life Science, Sano Ventures, Unilever Ventures and Zesiger Capital.
January 2003
Perlegen Sciences raises a $30,000,000 series C round from Alejandro Zaffaroni, Biofrontier Partners, CMEA Capital, CSK Venture Capital, Eli Lilly and Company, Maverick Ventures, SB Life Science and Unilever Ventures.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.